This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Influenza or Influenza-like Illness
and you are
over 65
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

This study is powered to prospectively evaluate the relative effectiveness of adjuvanted trivalent influenza vaccine (aTIV; FLUAD) in preventing influenza mortality, hospitalization, and functional decline in a nursing home population in the U.S., compared to the commercially available, standard dose trivalent seasonal influenza vaccine (TIV; Fluvirin).

Provided treatments

  • Biological: adjuvanted trivalent influenza vaccine
  • Biological: trivalent influenza vaccine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02882100. The sponsor of the trial is Insight Therapeutics, LLC and it is looking for 823 volunteers for the current phase.
Official trial title:
Adjuvanted Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes